top of page
Medex EU Authorised Representative logo

EU Authorized Representative for Ultrasound and Bone Densitometer Manufacturers: Rule 10, Rule 9 and the Mandate

Diagnostic ultrasound and quantitative ultrasound bone densitometers are class IIa under the first indent of Rule 10 of Annex VIII to Regulation (EU) 2017/745. A DXA densitometer emits ionising radiation and is class IIb under the last paragraph of the same rule. Therapeutic ultrasound follows Rule 9. In every case a notified body is involved, and a manufacturer outside the EU must designate a sole authorized representative under Article 11(1).

Which products this page covers

This page covers diagnostic ultrasound systems and their transducers, point-of-care and handheld ultrasound probes, quantitative ultrasound bone densitometers, dual-energy X-ray absorptiometry (DXA) bone densitometers, therapeutic ultrasound equipment and ultrasound gels. These products sit under three different rules of Annex VIII, and the energy used, not the clinical field, decides which one.

Rule 10: diagnostic ultrasound and ultrasound densitometers

Rule 10 opens with devices that put energy into the body in order to obtain diagnostic information:

"Active devices intended for diagnosis and monitoring are classified as class IIa:"

Source: Regulation (EU) 2017/745, Annex VIII, Rule 10

"if they are intended to supply energy which will be absorbed by the human body, except for devices intended to illuminate the patient's body, in the visible spectrum, in which case they are classified as class I;"

Source: Regulation (EU) 2017/745, Annex VIII, Rule 10, first indent

MDCG 2021-24 lists diagnostic ultrasound as a class IIa example under that indent. A quantitative ultrasound bone densitometer supplies ultrasound energy that is absorbed by the heel or forearm to measure bone parameters and falls under the same indent, class IIa. The class I exception in that indent is for visible-light illumination only and does not reach ultrasound.

Rule 10, last paragraph: X-ray bone densitometers

A DXA densitometer uses ionising radiation and is governed by the closing paragraph of Rule 10:

"Active devices intended to emit ionizing radiation and intended for diagnostic or therapeutic radiology, including interventional radiology devices and devices which control or monitor such devices, or which directly influence their performance, are classified as class IIb."

Source: Regulation (EU) 2017/745, Annex VIII, Rule 10

The result is class IIb, the same as the diagnostic X-ray machines and computed tomography devices MDCG 2021-24 lists under that paragraph. This is the main classification split within the bone densitometry group: ultrasound densitometers are class IIa, X-ray densitometers are class IIb.

Rule 9: therapeutic ultrasound

Ultrasound equipment with a therapeutic purpose is an active therapeutic device and is classified under Rule 9:

"All active therapeutic devices intended to administer or exchange energy are classified as class IIa unless their characteristics are such that they may administer energy to or exchange energy with the human body in a potentially hazardous way, taking account of the nature, the density and site of application of the energy, in which case they are classified as class IIb."

Source: Regulation (EU) 2017/745, Annex VIII, Rule 9

MDCG 2021-24 places ultrasound equipment for physiotherapy under the class IIa branch and lithotriptors, surgical ultrasound devices and high-intensity focused ultrasound (HIFU) under the class IIb branch. Ultrasound equipment with both a diagnostic and a therapeutic function is classified by the stricter rule under Section 3.5 of Annex VIII.

Transducers, gels and software

Accessories and software are classified separately under Section 3.2 of Annex VIII. A transducer that forms part of the ultrasound system takes the class of the system. Ultrasound gel is a non-invasive device in contact with intact skin; MDCG 2021-24 lists non-invasive conductive gels, i.e. ultrasound gels, as class I under Rule 1 and notes that they are not absorbed or locally dispersed in the body. Image analysis software sold separately is classified under Rule 11 in its own right; see medical device software. Ultrasound probes that enter a body orifice, such as transvaginal or transoesophageal probes, bring Rule 5 into play as invasive devices connected to a class IIa active device, which under the last sentence of Rule 5 gives class IIa.

Classification table

Product variantClassRuleNotified body
Diagnostic ultrasound system, cart-based or handheldIIaAnnex VIII, Rule 10, first indentYes
Quantitative ultrasound bone densitometerIIaAnnex VIII, Rule 10, first indentYes
Dual-energy X-ray absorptiometry (DXA) bone densitometerIIbAnnex VIII, Rule 10, last paragraphYes
Ultrasound equipment for physiotherapyIIaAnnex VIII, Rule 9, first branchYes
Lithotriptor, surgical ultrasound device, HIFUIIbAnnex VIII, Rule 9, second branchYes
Transvaginal or transoesophageal ultrasound probeIIaAnnex VIII, Rule 5, last sentence; Rule 10Yes
Ultrasound gelIAnnex VIII, Rule 1None unless sterile

Notified body involvement

Every active product in the table is class IIa or IIb, so a notified body is involved:

"Manufacturers of class IIa devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Chapters I and III of Annex IX, and including an assessment of the technical documentation as specified in Section 4 of that Annex of at least one representative device for each category of devices."

Source: Regulation (EU) 2017/745, Article 52(6)

Class IIb DXA densitometers and HIFU equipment follow Article 52(4), which adds assessment of the technical documentation of at least one representative device per generic device group. Ultrasound gel in class I needs no notified body unless it is placed on the market sterile, in which case Article 52(7)(a) applies.

The authorized representative: Article 11

Whether an ultrasound or bone densitometry manufacturer needs an EU authorized representative does not depend on the class of the product. It depends on where the manufacturer is established. Article 11(1) is the operative sentence:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative."

Source: Regulation (EU) 2017/745, Article 11(1)

Article 11(2) requires the mandate to be accepted in writing and to cover at least all devices of the same generic device group. Article 11(3) then lists the minimum tasks. For imaging equipment the representative also keeps the certificate and its supplements, because transducer ranges and software versions are added over the life of the system.

"(a) verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"

Source: Regulation (EU) 2017/745, Article 11(3)(a)

"(b) keep available a copy of the technical documentation, the EU declaration of conformity and, if applicable, a copy of the relevant certificate, including any amendments and supplements, issued in accordance with Article 56, at the disposal of competent authorities for the period referred to in Article 10(8);"

Source: Regulation (EU) 2017/745, Article 11(3)(b)

"(g) immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"

Source: Regulation (EU) 2017/745, Article 11(3)(g)

One mandate for the European Union and Türkiye

Medex is established in Türkiye and registered in EUDAMED as an authorized representative under SRN TR-AR-000057550, so an ultrasound or bone densitometry manufacturer outside both the EU and Türkiye covers both markets with one mandate. MDCG 2022-16, footnote 1:

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey."

Source: MDCG 2022-16, Guidance on Authorised Representatives, footnote 1

The Commission's Notice to Stakeholders of March 2022 draws the conclusion:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey."

Source: European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices, Section I.2

Placing the product on the Turkish market also requires registration in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, a separate service under a separate contract: see ÜTS registration for foreign manufacturers and ultrasound device ÜTS registration in Türkiye (Turkish).

What Medex does under the mandate

We verify that the EU declaration of conformity and technical documentation for each ultrasound or bone densitometry device exist and that the notified body procedure has been carried out, keep copies for the period in Article 10(8), register in EUDAMED and check your Basic UDI-DI records, answer competent authority requests, cooperate on corrective actions and pass complaints and suspected incidents to you without delay. A person responsible for regulatory compliance is available in-house.

A class IIa ultrasound system falls in the band of €1,000 to 1,300 per year and a class IIb DXA densitometer in the band of €1,200 to 1,600 per year, fixed for three years from signature. Setup is €0 and a change of representative costs nothing; see pricing and EU authorized representative cost. We do not carry out acoustic output or radiation safety testing. We are not a notified body and we do not find importers or distributors. Offices in Ankara and İstanbul.

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related pages

Other active diagnostic equipment with its own page includes ECG devices, endoscopes and blood pressure monitors and thermometers. All groups are listed on the medical device categories page. The general guide is EU authorized representative.

Frequently asked questions

What class is a diagnostic ultrasound scanner under the MDR?

Class IIa. Rule 10 places active diagnostic devices that supply energy absorbed by the human body in class IIa, and MDCG 2021-24 lists diagnostic ultrasound as an example under that indent.

Are bone densitometers class IIa or IIb?

It depends on the energy. A quantitative ultrasound densitometer is class IIa under the first indent of Rule 10. A DXA densitometer emits ionising radiation for diagnostic radiology and is class IIb under the last paragraph of Rule 10.

Is ultrasound gel a medical device, and what class?

MDCG 2021-24 lists non-invasive conductive gels, i.e. ultrasound gels, as class I under Rule 1. If the gel is placed on the market sterile, Article 52(7)(a) brings in a notified body for the sterility aspects only.

Does a handheld ultrasound probe sold with an app need a separate classification for the app?

The software is classified in its own right under Section 3.2 of Annex VIII. Software that drives the probe takes the class of the probe under Section 3.3; software that analyses images for diagnostic decisions is classified under Rule 11.

Does one Medex mandate cover the EU and Türkiye for ultrasound equipment?

Yes. MDCG 2022-16 notes that the Union market extends via the Customs Union Agreement to Turkey, and the Commission Notice of March 2022 confirms that one authorized representative, in the EU or in Türkiye, is enough for a manufacturer outside both.

Sources and further reading

Regulation (EU) 2017/745 on medical devices, consolidated text: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20250110

MDCG 2021-24, Guidance on classification of medical devices: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en

MDCG 2022-16, Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022): health.ec.europa.eu/system/files/2022-04/md_eu-turkey_customs-union_en.pdf

Request a fixed-price EU authorized representative quote for your ultrasound or bone densitometry equipment.

Request a proposal  ·  View pricing  ·  Appoint Medex as your authorized representative

bottom of page